Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis

Explore clinical trials studying Hidradenitis. Study availability and eligibility vary by location and protocol.

196 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis trial results

Active, not recruiting

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

NCT06785675

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Al Ain Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Ras al-Khaimah, United Arab Emirates
  • Novartis Investigative Site Sharjah city, United Arab Emirates
View Trial Details
Active, not recruiting

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

NCT06517732

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Izhevsk, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kazan', Russia
View all 19 locations
View Trial Details
Active, not recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details
Active, not recruiting

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

NCT06361836

Conditions
Autoimmune Diseases, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • SLUCare Academic Pavillion St Louis, Missouri, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, not recruiting

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

NCT05139602

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Medical Dermatology Specialists /ID# 240641 Phoenix, Arizona, United States
  • Mayo Clinic - Scottsdale /ID# 241030 Scottsdale, Arizona, United States
  • Burke Pharmaceutical Research /ID# 240811 Hot Springs, Arkansas, United States
  • UCSF Fresno /ID# 240903 Fresno, California, United States
View all 54 locations
View Trial Details
Active, not recruiting

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT03827798

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Olympian Clinical Research Clearwater, Florida, United States
  • Park Avenue Dermatology PA Orange Park, Florida, United States
  • University Of South Florida Tampa, Florida, United States
  • Advanced Medical Research Sandy Springs, Georgia, United States
View all 36 locations
View Trial Details
Active, not recruiting

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

NCT06444087

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Nice, France
  • Novartis Investigative Site Antony, France
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Brest, France
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04242446

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Hs0003 50140 Birmingham, Alabama, United States
  • Hs0003 50175 Phoenix, Arizona, United States
  • Hs0003 50161 Los Angeles, California, United States
  • Hs0003 50220 San Diego, California, United States
View all 88 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04242498

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Hs0004 50162 Fountain Valley, California, United States
  • Hs0004 50196 Thousand Oaks, California, United States
  • Hs0004 50199 Miami, Florida, United States
  • Hs0004 50152 Orange Park, Florida, United States
View all 91 locations
View Trial Details
Completed

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04901195

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Hs0005 50140 Birmingham, Alabama, United States
  • Hs0005 50175 Phoenix, Arizona, United States
  • Hs0005 50162 Fountain Valley, California, United States
  • Hs0005 50161 Los Angeles, California, United States
View all 145 locations
View Trial Details

Related conditions